Senner Christopher J.
- SEC CIK
- 0001648367
In the past year, 2 open-market sale filings worth $4.56M and no purchases.
Current role at each company
- QNCX Quince Therapeutics, Inc.Directoras of Jun 15, 2026
- EXEL Exelixis, Inc.EVP and CFOas of May 19, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.56M
- 2 filings
- Net
- −$4.56M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Senner Christopher J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXEL Exelixis, Inc.
EVP and CFO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 (view filing) | Aug 3-4 | 4 days | Senner Christopher J.EVP and CFO | SSale | −120.0K | $20.60 | −$2.47M | −17.4%571.6K after | 2 lots |
| Aug 9, 2024 (view filing) | Aug 9 | Same day | Senner Christopher J.EVP and CFO | SSale | −125.0K | $27.19 | −$3.40M | −14.8%721.7K after | |
| Feb 26, 2025 (view filing) | Feb 24 | 2 days | Senner Christopher J.EVP and CFO | SSale | −29.3K | $36.14 | −$1.06M | −3.6%779.6K after | |
| May 16, 2025 (view filing) | May 16 | Same day | Senner Christopher J.EVP and CFO | SSale | −100.0K | $46.00 | −$4.60M | −9.4%967.8K after | |
| Feb 18, 2026 (view filing) | Feb 13-17 | 5 days | Senner Christopher J.EVP and CFO | SSale | −64.9K | $43.32 | −$2.81M | −6.2%976.1K after | 2 lots |
| May 19, 2026 (view filing) | May 18 | 1 day | Senner Christopher J.EVP and CFO | SSale | −34.9K | $50.00 | −$1.75M | −3.5%952.3K after |